PsychEd: Educational Psychiatry Podcast

Welcome to PsychEd — the psychiatry podcast for medical learners, by medical learners. This episode covers the mental status examination and makes use of practical and fictional examples to delve deeper into the skills and concepts

 

Learning Objectives:

 

The learning objectives for this episode are as follows:

By the end of this episode, the listener will be able to…

1. Explain the utility and purpose of the mental status examination in psychiatry

2. Describe the major components of the mental status examination and be familiar with some of the common vocabulary used

3. Incorporate the mental status in a way that respects patients in presentation, documentation and formulation in clinical practice 

 

Topics:

• 2:37 - Learning objectives

• 3:10 - Definition of the MSE

• 6:48 - History of the MSE

• 9:00 - Limitations of the MSE

• 15:37 - Strengths of the MSE

• 21:30 - ASEPTIC Mnemonic

• 23:04 - Appearance and Behaviour

• 37:42 - Speech

• 51:51 - Emotion (mood and affect)

• 1:03:51 - Perception

• 1:08:38 - Thought Form and Content

• 1:17:30 - Insight and Judgement

• 1:27:40 - Cognition

 

Hosts: Andreea Chiorean (CC4), Saja Jaberi (IMG), Dr. Weam Seiffien (PGY2), Angad Singh (CC2), Dr. Annie Yu (PGY1), and Dr. Alex Raben, staff psychiatrist.

 

Guest Experts: Us!

 

Video clips:

• Speech: 

• Mojo Jojo: https://youtu.be/y4qNWPPlYE4?t=48

• Family guy video: no longer available

 

• Emotion

• Eeyore: https://youtu.be/7xPnUe6Xcbw?t=12

 

• Squidward: https://youtu.be/FjrOWnywPok?t=195

 

• Bubbles: https://youtu.be/rAC4W563Ayk?t=339

 

• Perception

• A Beautiful Mind: https://youtu.be/vNa37tOB4rE

 

• Insight and Judgement

• Simpsons: no longer available

• Mr. Magoo: https://youtu.be/eWEnzLFd4P4?t=201

 

• Cognition

• Still Alice: https://youtu.be/mhiXAJO8kBc?t=67

Resources:

• MSE template: https://www.therapistaid.com/therapy-worksheet/mental-status-exam

• Emotion wheel: https://feelingswheel.com/

• MSE vocabulary: http://www.columbia.edu/itc/hs/medical/psychmed/1_2004/mental_status_exam.pdf

References:

• Bell, R. (1977). The Mental Status Examination. 16(5).Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. Journal of psychiatric research, 12(3), 189-198.

• Donnelly, J., Rosenberg, M., & Fleeson, W. P. (1970). The evolution of the mental status—past and future. American Journal of Psychiatry, 126(7), 997-1002.

• Norris, D. R., Clark, M. S., & Shipley, S. (2016). The Mental Status Examination. 94(8).

• Norton, J. W., & Corbett, J. J. (2000, February). Visual perceptual abnormalities: hallucinations and illusions. In Seminars in neurology (Vol. 20, No. 01, pp. 0111-0122). Copyright© 2000 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

• Notes, T. (2020). Comprehensive Medical Reference and Review for the Medical Council of Canada Qualifying Exam (MCCQE) Part I and the United States Medical Licensing Exam (USMLE) Step II 36th ed: Toronto Notes for Medical Students.

• Recupero, P. R. (2010). The Mental Status Examination in the Age of the Internet. The Journal of the American Academy of Psychiatry and the Law, 38(1).

• Robinson D. J. (2002). Mental status exam explained (2nd ed.). Rapid Psychler Press.

• Robinson D. J. (1998). Brain Calipers: a guide to a successful mental status exam. Rapid Psychler Press.

• Ross, C. A., & Leichner, P. (1988). Residents Performance on the Mental Status Examination. The Canadian Journal of Psychiatry, 33(2), 108–111. https://doi.org/10.1177/070674378803300207

• Sadock, B. J., & Sadock, V. A. (2007). Kaplan & Sadock's synopsis of psychiatry: Behavioral sciences/clinical psychiatry (10th ed.). Lippincott Williams & Wilkins Publishers.

• Segal, D. L. (Ed.). (2019). Diagnostic interviewing. Springer.

• Snyderman, D., & Rovner, B. (2009). Mental status examination in primary care: a review. American family physician, 80(8), 809-814.

• Spencer, R. J., Noyes, E. T., Bair, J. L., & Ransom, M. T. (2022). Systematic Review of the Psychometric Properties of the Saint Louis University Mental Status (SLUMS) Examination. Clinical Gerontologist, 45(3), 454–466. https://doi.org/10.1080/07317115.2022.2032523

• The Collected Papers of Adolf Meyer. Volume III: Medical Teaching. (1952) JAMA. 148(17):1544.

• https://www.statpearls.com/ArticleLibrary/viewarticle/24998

CPA Note: The views expressed in this podcast do not necessarily reflect those of the Canadian Psychiatric Association.

For more PsychEd, follow us on Twitter (@psychedpodcast), Facebook (PsychEd Podcast), and Instagram (@psyched.podcast). You can provide feedback by email at [email protected]. For more information, visit our website at psychedpodcast.org.

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. In this episode, we’ll explore a topic that we’re sure many listeners are eager to learn about: The Assessment of Major Neurocognitive Disorder, also known as dementia with Dr. Lesley Wiesenfeld who is a Geriatric Psychiatrist and Psychiatrist-in-Chief at Mount Sinai Hospital in Toronto, where she leads the Geriatric Consult Liaison Psychiatry Service. She is also an Associate Professor in the Department of Psychiatry at the University of Toronto.

 

The learning objectives for this episode are as follows:

 

1. Define Major Neurocognitive Disorder (aka Dementia) as per DSM-5 diagnostic criteria

2. Identify differential diagnoses for cognitive decline and list differentiating clinical features 

3. Outline an approach to the assessment of a patient presenting with cognitive decline, including the role of a comprehensive history, psychometric tools and other investigations [ Relevant PMH/risk factors, ADLs/IADLs to cover on history, psychometric tools such as MMSE, MoCA and tie this back into major cognitive domains when to consider imaging, bloodwork including specialized testing such as ApoE genetic tests] 

4. Classify the major subtypes of Neurocognitive Disorders, their epidemiology, and clinical presentations [ Vascular dementia, Alzheimer’s, Frontotemporal, Lewy Body, Parkinson’s,    Mixed dementia - Early onset dementia]

 

Guest: Dr. Lesley Wiesenfeld ( [email protected] )

 

Hosts: Dr. Luke Fraccaro (PGY-3), Dr. Mark Fraccaro (PGY-4), Sena Gok (international medical graduate)

 

Audio editing by: Sena Gok

 

Show notes by: Sena Gok

 

Interview Content:

Introduction: 0:13

Learning Objectives: 02:35

Diagnostic criteria of Major Neurocognitive Disorder: 03:20

Difference between Major and Mild Neurocognitive Disorder: 05:20

Red Flags of Cognitive Declines: 06:50

Normal Aging vs Major Neurocognitive Disorder: 10:00

Clinical Vignette – introduction: 11:35

Patient Assessment: 16:50

Past medical/family / Psychosocial history: 21:55

Clinical Vignette - Assessment: 37:45

Physical examination: 43:50

Investigations: 45:53

Role of genetic testing: 53:24

Clinical Vignette – Diagnosis: 57:50

 

References:

 

• American Psychiatric Association. (2022). Neurocognitive Disorders. In Diagnostic and statistical manual of mental disorders (5th ed., text rev.).

 

• Sadock, B. J., Sadock, V. A., Ruiz, P., & Kaplan, H. I. (2015). Neurocognitive Disorders. Kaplan and Sadock’s Synopsis of Psychiatry (11th ed.). Wolters Kluwer

 

• DSM-5-TR Fact Sheets (https://psychiatry.org/psychiatrists/practice/dsm/educational-resources/dsm-5-tr-fact-sheets )

 

• Gauthier S, Patterson C, Chertkow H, Gordon M, Herrmann N, Rockwood K, Rosa-Neto P, Soucy JP. Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4). Can Geriatr J. 2012 Dec;15(4):120-6. doi: 10.5770/cgj.15.49. Epub 2012 Dec 4. PMID: 23259025; PMCID: PMC3516356.

 

• Gauthier S, Chertkow H, Theriault J, Chayer C, Ménard MC, Lacombe G, Rosa-Neto P, Ismail Z. CCCDTD5: research diagnostic criteria for Alzheimer's Disease. Alzheimers Dement (N Y). 2020 Aug 25;6(1):e12036. doi: 10.1002/trc2.12036. Erratum in: Alzheimers Dement (N Y). 2022 Feb 03;6(1):e12088. PMID: 32864413; PMCID: PMC7446944.

CPA Note: The views expressed in this podcast do not necessarily reflect those of the Canadian Psychiatric Association.

 

For more PsychEd, follow us on Twitter (@psychedpodcast), Facebook (PsychEd Podcast), and Instagram (@psyched.podcast). You can provide feedback by email at [email protected]. For more information, visit our website at psychedpodcast.org.

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode delves into the history of psychiatry with Dr David Castle, the inaugural Scientific Director of the Centre for Complex Interventions at the Centre for Addictions and Mental Health and a Professor in the Department of Psychiatry at the University of Toronto. Prior to migrating to Canada in 2021, he spent 15 years as a Professor of Psychiatry at St Vincent’s Hospital and the University of Melbourne in Australia.

 

The learning objectives for this episode are as follows:

 

By the end of this episode, you should be able to…

1. Gain an appreciation for the historical context of the field of psychiatry
2. Understand how illness categories and treatments have been shaped by this history 
3. Compare and contrast how various past societies viewed and conceptualized mental illness
4. Apply lessons learned from historical practices to appraise current approaches

 

Guest: Dr David Castle

 

Hosts: Dr Alex Raben (Staff Psychiatrist), Gaurav Sharma (PGY4), Nikhita Singhal (PGY4), Andreea Chiorean (CC4)

 

Audio editing by: Dr Alex Raben

 

Show notes by: Dr Nikhita Singhal

 

Interview Content:

 

1:45 - Learning Objectives

 

3:25 - Ancient Times

 

14:42 - Middles Ages 

 

23:56 - Renaissance to Enlightenment

 

34:55 - 19th-20th Centuries

 

47:55 - 20th-21st Centuries

 

1:00:48 - Final Thoughts

 

Resources:

• Shrinks: The Untold Story of Psychiatry (Jeffrey A Lieberman)

 

References:

• The Emotional Foundations of Personality: A Neurobiological and Evolutionary Approach (Kenneth L Davis, Jaak Panksepp)
• Illustration of Bedlam (William Hogarth)
• Pinel, médecin en chef de la Salpêtrière en 1795 (Tony Robert-Fleury)
• Castle, D., Bassett, D., King, J., & Gleason, A. (2013). A primer of clinical psychiatry. Elsevier Health Sciences.
• de Leon J. DSM-5 and the research domain criteria: 100 years after Jaspers' General psychopathology. Am J Psychiatry. 2014 May;171(5):492-4. https://doi.org/10.1176/appi.ajp.2013.13091218
• Eisenberg L. Mindlessness and brainlessness in psychiatry. Br J Psychiatry. 1986 May;148:497-508. https://doi.org/10.1192/bjp.148.5.497
• Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977 Apr 8;196(4286):129-36. https://doi.org/10.1126/science.847460
• Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry. 2003 Jan;160(1):4-12. https://doi.org/10.1176/appi.ajp.160.1.4
• Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry. 1970 Jan;126(7):983-7. https://doi.org/10.1176/ajp.126.7.983
• Rosenhan DL. On being sane in insane places. Science. 1973 Jan 19;179(4070):250-8. https://doi.org/10.1126/science.179.4070.250
• Scheff TJ. The labelling theory of mental illness. Am Sociol Rev. 1974 Jun;39(3):444-52. https://doi.org/10.2307/2094300
• Szasz T. The myth of mental illness: 50 years later. The Psychiatrist. Cambridge University Press; 2011;35(5):179–182. https://doi.org/10.1192/pb.bp.110.031310

 

CPA Note: The views expressed in this podcast do not necessarily reflect those of the Canadian Psychiatric Association.

 

For more PsychEd, follow us on Twitter (@psychedpodcast), Facebook (PsychEd Podcast), and Instagram (@psyched.podcast). You can provide feedback by email at [email protected]. For more information, visit our website at psychedpodcast.org.

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. In this episode, we present a focused summary of the latest changes in The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) with our guest expert — Dr. Michael First, a Professor of Clinical Psychiatry at Columbia University, NY. Dr. First is an internationally recognized expert on psychiatric diagnosis and assessment issues, he is the editor and co-chair of the DSM-5 text revision project (DSM-5-TR), the editorial and coding Consultant for the DSM-5, the chief technical and editorial consultant on the World Health Organization ICD-11 revision project and was an external consultant to the NIMH Research Domain Criteria project (RDOC).

 

The learning objectives for this episode are as follows:

1. Understand the rationale for undertaking a DSM-5-TR as well as the revision process itself

2.  To become familiar with disorder, text and symptom code additions and modifications to the DSM-5-TR

3.  To understand the purpose and function of the DSM in its current form and be able to contemplate future directions

 

Guest Expert: Dr. Michael First – staff psychiatrist and professor of clinical psychiatry at Columbia University, USA.

Produced and hosted by: Dr. Alex Raben (staff psychiatrist) and Saja Jaberi (international medical graduate)

Audio editing by: Dr. Alex Raben

Show notes by: Saja Jaberi

Interview Content:

2:53 - Learning objectives

3:34 - Brief description of the DSM and its history

4:54 – ICD vs. DSM 

7:43 - Rationale behind the new revision

11:11 - Characteristics of the DSM-5-TR revision process and the people behind it

16:54 - Case presentation and Differential Diagnosis

23:07 - Prolonged Greif disorder

27:04 - Most important changes to the terminology used in the manual

39:34 - Pros and cons of the DSM

44:30 - A brief Comparison to the RDOC Framework

49:04 – Future Directions of the DSM

 

References

• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. 2013.

• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th Text Revision ed. 2022.

•  DSM-5-TR Fact Sheets https://psychiatry.org/psychiatrists/practice/dsm/educational-resources/dsm-5-tr-fact-sheets

 

CPA Note: The views expressed in this podcast do not necessarily reflect those of the Canadian Psychiatric Association.

 

For more PsychEd, follow us on Twitter (@psychedpodcast), Facebook (PsychEd Podcast), and Instagram (@psyched.podcast). You can provide feedback by email at [email protected]. For more information, visit our website at psychedpodcast.org.

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. In this episode, we present a broad overview of antisocial personality disorder and psychopathy with our guest expert - Dr. Donald Lynam. Dr. Lynam is a clinical psychologist by training, and professor at Purdue university, where he heads the Purdue's Developmental Psychopathology, Psychopathy and Personality Lab. While there may be some disagreement in the field, Dr. Lynam and I discuss how ASPD and psychopathy are two diagnostic constructs that are attempting to outline the same psychopathology, with the main difference being the degree of severity - for this reason, we use the terms antisocial and psychopathic interchangeably. 

 

While not necessary, it may be of benefit for listeners to familiarize themselves with the DSM-V criteria for antisocial personality disorder, the psychopathy checklist (PCL), as well as the 5-factor model of personality. References for each are listed below in the references section, however, for a brief overview, one could do a quick google image search for each term (Wikipedia also has a succinct overview of the psychopathy checklist).

 

The learning objectives for this episode are as follows:

 

1. Develop a basic understanding of what is meant by antisocial personality and psychopathy

2. Be aware of some of the classic traits and characteristics of antisocial/psychopathic personalities, and the general functions of these behaviors 

3. Describe the theoretical basis for the development of antisocial personalities 

 

Guest Expert: Dr. Donald Lynam - Clinical psychologist, Investigator at Purdue University, Indiana

Produced and hosted by: Dr. Chase Thompson (PGY5 in Psychiatry)

Episode guidance and feedback: Dr. Gaurav Sharma (PGY4 in Psychiatry)

 

Interview Content:

 

0:50 - Learning objectives

1:40 - Dr. Lynam discusses his path to his current research interests

3:40 - Defining the terms antisocial personality disorder, sociopathy, psychopathy

8:30 - Discussing the possibility of antisocial behaviors without an antisocial personality

12:07 - Laying out the core features of antisocial individuals 

18:20 - Antisocial personality from the perspective of the Big 5 personality model

22:00 - Discussion of the high-functioning psychopathy 

25:06 - Prevalence of psychopathy

30:10 - Factors relevant to the development of psychopathy

39:30 - Prognosis and clinical trajectory 

44:30 - Comorbid psychopathology 

46:30 - Functions of antagonism or antisocial behaviours 

49:30 - Treatment 

 

References

 

• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. 2013.

• Broidy LM, Nagin DS, Tremblay RE, Bates JE, Brame B, Dodge KA, Fergusson D, Horwood JL, Loeber R, Laird R, Lynam DR. Developmental trajectories of childhood disruptive behaviors and adolescent delinquency: a six-site, cross-national study. Developmental psychology. 2003 Mar;39(2):222.

• Babiak P, Hare RD, McLaren T. Snakes in suits: When psychopaths go to work. New York: Harper; 2007 May 8.

• Hare RD. The psychopathy checklist–Revised. Toronto, ON. 2003;412.

• Hare RD, Harpur TJ, Hakstian AR, Forth AE, Hart SD, Newman JP. The revised psychopathy checklist: reliability and factor structure. Psychological Assessment: A Journal of Consulting and Clinical Psychology. 1990 Sep;2(3):338.

• Hare RD, Hart SD, Harpur TJ. Psychopathy and the DSM-IV criteria for antisocial personality disorder. Journal of abnormal psychology. 1991 Aug;100(3):391.

• Jones SE, Miller JD, Lynam DR. Personality, antisocial behavior, and aggression: A meta-analytic review. Journal of Criminal Justice. 2011 Jul 1;39(4):329-37.

• Lynam DR. Early identification of chronic offenders: Who is the fledgling psychopath?. Psychological bulletin. 1996 Sep;120(2):209.

• Miller JD, Lynam DR. Psychopathy and the five-factor model of personality: A replication and extension. Journal of personality assessment. 2003 Oct 1;81(2):168-78.

 

CPA Note: The views expressed in this podcast do not necessarily reflect those of the Canadian Psychiatric Association.

For more PsychEd, follow us on Twitter (@psychedpodcast), Facebook (PsychEd Podcast), and Instagram (@psyched.podcast). You can provide feedback by email at [email protected]. For more information, visit our website at psychedpodcast.org.

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers perinatal psychiatry with Dr. Tuong Vi Nguyen, Assistant Professor, Department of Psychiatry, Faculty of Medicine and Health Sciences, McGill University and Scientist and Scientist, RI-MUHC, Brain Repair and Integrative Neuroscience (BRaIN) Program, Centre for Outcomes Research and Evaluation. 

 

The learning objectives for this episode are as follows:

 

By the end of this episode, you should be able to…

1. Define the field of perinatal psychiatry
2. Describe the key issues that should be addressed in pre-conception psychiatric counseling
3. Discuss the management approach for prescribing medications during pregnancy
4. Recognize the prevalence of mood disorders during the perinatal period
5. Recall the diagnostic criteria for postpartum depression
6. Consider the risk factors and explanatory models for postpartum depression
7. Discuss the use of screening tools for postpartum depression
8. Outline the treatment for postpartum depression
9. Describe the clinical presentation of postpartum psychosis and recognize the urgency of this condition
10. List important risk factors for postpartum psychosis
11. Discuss the management for postpartum psychosis

 

Guest: Dr. Tuong Vi Nguyen

 

Hosts: Nima Nahiddi (PGY4), Audrey Le (PGY1), and Arielle Geist (PGY2) 

 

Produced by: Nima Nahiddi (PGY4), Audrey Le (PGY1), Rebecca Marsh (PGY2) and Arielle Geist (PGY2) 

 

Audio editing by: Audrey Le

 

Show notes by: Arielle Geist 

 

Interview content:

• Introduction - 00:00
• Learning objectives - 00:43
• Defining the field of perinatal psychiatry - 01:55
• Key issues to address in preconception counseling - 02:50
• Management approach for prescribing medications during pregnancy - 07:00
• Prevalence of mood disorders during the perinatal period - 12:11
• Diagnostic criteria for postpartum depression - 14:05
• Differentiating postpartum psychosis from postpartum depression - 16:52
• Risk factors and explanatory models for postpartum depression - 18:58
• Screening tools for postpartum depression - 20:15
• Treatment for postpartum depression - 22:13
• Pharmacotherapy - 22:20
• Psychotherapy - 27:34
• Clinical presentation of postpartum psychosis - 29:07
• Risk factors for postpartum psychosis - 30:43
• Postpartum psychosis prognosis and impacts on attachment- 32:57
• Management of postpartum psychosis -35:30
• Closing comments - 38:00

 

Resources:

• Bérard, A., Zhao, J. P., & Sheehy, O. (2017). Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort. BMJ open, 7(1), e013372. https://doi.org/10.1136/bmjopen-2016-013372
• Boukhris, T., Sheehy, O., Mottron, L., & Bérard, A. (2016). Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in Children. Jama Pediatrics, 170(2), 117-24. doi: 10.1001/jamapediatrics.2015.3356.
• Brown, A. S., Gyllenberg, D., Malm, H., McKeague, I. W., Hinkka-Yli-Salomäki, S., Artama, M., Gissler, M., Cheslack-Postava, K., Weissman, M. M., Gingrich, J. A., & Sourander, A. (2016). Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring. JAMA psychiatry, 73(11), 1163–1170. https://doi.org/10.1001/jamapsychiatry.2016.2594
• Cohen, J. , Hernández-Díaz, S. , Bateman, B. , Park, Y. , Desai, R. , Gray, K. , Patorno, E. , Mogun, H. & Huybrechts, K. (2017). Placental Complications Associated With Psychostimulant Use in Pregnancy. Obstetrics & Gynecology, 130(6), 1192-1201. doi: 10.1097/AOG.0000000000002362.
• Huybrechts, K. F., Hernández-Díaz, S., Patorno, E., Desai, R. J., Mogun, H., Dejene, S. Z., Cohen, J. M., Panchaud, A., Cohen, L., & Bateman, B. T. (2016). Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations. JAMA psychiatry, 73(9), 938–946. https://doi.org/10.1001/jamapsychiatry.2016.1520
• Huybrechts, K. F., Palmsten, K., Avorn, J., Cohen, L. S., Holmes, L. B., Franklin, J. M., Mogun, H., Levin, R., Kowal, M., Setoguchi, S., & Hernández-Díaz, S. (2014). Antidepressant use in pregnancy and the risk of cardiac defects. The New England Journal of Medicine, 370(25), 2397–2407. https://doi.org/10.1056/NEJMoa1312828
• Imaz, M. L., Oriolo, G., Torra, M., Soy, D., García-Esteve, L., & Martin-Santos, R. (2018). Clozapine Use During Pregnancy and Lactation: A Case-Series Report. Frontiers in Pharmacology, 9, 264. https://doi.org/10.3389/fphar.2018.00264
• Nörby, U., Forsberg, L., Wide, K., Sjörs, G., Winbladh, B., & Källén, K. (2016). Neonatal Morbidity After Maternal Use of Antidepressant Drugs During Pregnancy. Pediatrics, 138(5), e20160181. https://doi.org/10.1542/peds.2016-0181
• Nörby, U., Winbladh, B., & Källén, K. (2017). Perinatal Outcomes After Treatment With ADHD Medication During Pregnancy. Pediatrics, 140(6), e20170747. https://doi.org/10.1542/peds.2017-0747
• Reis, M., & Källén, B. (2013). Combined use of selective serotonin reuptake inhibitors and sedatives/hypnotics during pregnancy: risk of relatively severe congenital malformations or cardiac defects. A registered study. BMJ Open, 3, e002166. doi:10.1136/bmjopen-2012-002166
• Sundram S. (2006). Cannabis and neurodevelopment: implications for psychiatric disorders. Human psychopharmacology, 21(4), 245–254. https://doi.org/10.1002/hup.762

 

References:

• Boland, R., Verduin, M., & Ruiz, P. (2021). Psychopharmacology. In Kaplan & Sadock's synopsis of psychiatry (Twelfth edition.). Philadelphia: Wolters Kluwer.
• Jones, I., Chandra, P.S., Dazzan, P., & Howard, L.K. (2014). Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period. Lancet, 384(9956), 1789-1799. doi: 10.1016/S0140-6736(14)61278-2.
• Nieldson, D., Videbech, P., Hedegaard, M., Dalby, J., & Secher, N.J. (2005). Postpartum depression: identification of women at risk. An International Journal of Obstetrics and Gynaecology, 107(10), 1210-1217. https://doi-org.myaccess.library.utoronto.ca/10.1111/j.1471-0528.2000.tb11609.x
• Schiller, C.E., Meltzer-Brody, S., & Rubinow, D.R. (2015). The role of reproductive hormones in postpartum depression. CNS Spectrums, 20(1), 48-59. doi: 10.1017/S1092852914000480
• Viguera, A. (2021). Mild to moderate postpartum unipolar major depression: Treatment. UpToDate. Accessed 2021-01-18.
• Wisner, K.L., Sit, D.K.Y., & McShea, M.C. (2013). Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings. JAMA Psychiatry, 70(5), 490-498. doi:10.1001/jamapsychiatry.2013.87

 

CPA Note: The views expressed in this podcast do not necessarily reflect those of the Canadian Psychiatric Association.

For more PsychEd, follow us on Twitter (@psychedpodcast), Facebook (PsychEd Podcast), and Instagram (@psyched.podcast). You can provide feedback by email at [email protected]. For more information, visit our website at psychedpodcast.org.

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers perinatal psychiatry with Dr. Tuong Vi Nguyen, Assistant Professor, Department of Psychiatry, Faculty of Medicine and Health Sciences, McGill University and Scientist, RI-MUHC, Brain Repair and Integrative Neuroscience (BRaIN) Program, Centre for Outcomes Research and Evaluation. 

 

The learning objectives for this episode are as follows:

 

By the end of this episode, you should be able to…

1. Define the field of reproductive psychiatry
2. Discuss the possible neurobiological pathways impacting mood and cognition during the reproductive cycle of women. 
3. Discuss the influence of sociocultural gender roles on psychopathology.   
4. List the DSM-V diagnostic criteria of premenstrual dysphoric disorder.
5. Recall the epidemiology of premenstrual dysphoric disorder.
6. Describe the steps in the diagnostic evaluation for premenstrual dysphoric disorder.
7. List lifestyle and psychopharmacologic interventions for premenstrual dysphoric disorder.
8. Discuss common mental health concerns during the perimenopausal period.

Guest: Dr. Tuong Vi Nguyen

 

Hosts: Nima Nahiddi (PGY4), Audrey Le (PGY1), and Arielle Geist (PGY2) 

 

Audio editing by: Audrey Le

 

Show notes by: Arielle Geist 

 

Interview content:

• Introduction - 00:00
• Learning objectives - 01:00
• Defining the field of perinatal psychiatry - 01:50
• Discussing neurobiological pathways impacting mood and cognition during the reproductive cycle - 02:47
• The influence of sociocultural gender roles on psychopathology -05:28
• DSM-V criteria of premenstrual dysphoric disorder - 11:18
• Epidemiology of premenstrual dysphoric disorder - 13:40
• Diagnostic evaluation of premenstrual dysphoric disorder - 14:38
• Management of premenstrual dysphoric disorder 
• Pharmacologic - 17:45
• Lifestyle - 24:15
• Perimenopausal period - 24:45
• Closing comments - 31:39

 

Resources:

• Brzezinski, A., Brzezinski-Sinai, N.A., & Seeman, M.V. (2017). Treating schizophrenia during menopause. Menopause, 24(5), 582-588. doi: 10.1097/GME.0000000000000772.
• Epperson, C.N., Steiner, M., Hartlage, A., Eriksson, E., Schmidt, P.J., Jones, I., & Yonkers, K.A. (2012). Premenstrual dysphoric disorder: evidence for a new category for DSM-5. The American Journal of Psychiatry, 169(5), 465-475. DOI: 10.1176/appi.ajp.2012.11081302
• Marsh, W.K., Gershenson, B., & Rothschild, A.J. (2015). Symptom severity of bipolar disorder during the menopausal transition. International Journal of Bipolar Disorders, 3(1), 35. DOI: 10.1186/s40345-015-0035-z
• Soares, C.N., Almeida, O.P.,  Joffe, H., & Cohen, L.S. (2001). Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women a double-blind, randomized, placebo-controlled trial. Archives of General Psychiatry, 58(6), 529-534. doi:10.1001/archpsyc.58.6.529
• Weber, M.T., Maki, P.M., & McDermott, M.P. (2013). Cognition and mood in perimenopause: A systematic review and meta-analysis. The Journal of Steroid Biochemistry and Molecular Biology, 142, 90-98. https://doi.org/10.1016/j.jsbmb.2013.06.001

 

References:

• Kornstein S.G., & Clayton, A.H. (2004). Sex differenes in neuroendocrine and neurotransmitter systems. In Women’s mental health: A comprehensive textbook (pp.3-30). Guilford Press. 
• Chrisler, J. C., & Johnston-Robledo, I. (2002). Raging hormones?: Feminist perspectives on premenstrual syndrome and postpartum depression. In M. Ballou & L. S. Brown (Eds.), Rethinking mental health and disorder: Feminist perspectives (pp. 174–197). Guilford Press.
• American Psychiatric Association. (2013). Depressive disorders. In Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596.

 

CPA Note: The views expressed in this podcast do not necessarily reflect those of the Canadian Psychiatric Association.

 

For more PsychEd, follow us on Twitter (@psychedpodcast), Facebook (PsychEd Podcast), and Instagram (@psyched.podcast). You can provide feedback by email at [email protected]. For more information, visit our website at psychedpodcast.org.

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers psychedelic-assisted psychotherapy with Dr Emma Hapke and Dr Daniel Rosenbaum, both of whom are psychiatrists at the University Health Network in Toronto and co-founders of UHN’s Nikean Psychedelic Psychotherapy Research Centre (in addition to being lecturers in the Department of Psychiatry at the University of Toronto).

 

The learning objectives for this episode are as follows:

 

By the end of this episode, you should be able to…

1. Briefly describe the history of psychedelics in psychiatry
2. List the four classes of psychedelic drugs and their mechanism of action
3. Summarize the evidence regarding psychedelic-assisted psychotherapy for various psychiatric disorders
4. Discuss patient selection considerations for psychedelic-assisted psychotherapy
5. Describe the safety, tolerability and possible side effects of psychedelic-assisted psychotherapy
6. Understand how a psychedelic-assisted psychotherapy session is practically carried out

 

Guests: Dr Emma Hapke and Dr Daniel Rosenbaum

 

Hosts: Dr Chase Thompson (PGY4), Dr Nikhita Singhal (PGY3), Jake Johnston (CC4), and Annie Yu (CC4)

 

Audio editing by: Nikhita Singhal

 

Show notes by: Nikhita Singhal

 

Interview Content:

• Introduction - 0:00
• Learning objectives - 02:47
• Definitions/categories of psychedelics - 03:24
• Classic psychedelics - 04:15
• Empathogens (e.g. MDMA) - 07:15
• Etymology of the term “psychedelic” - 09:30
• Ketamine - 12:24
• Iboga - 13:28
• Brief history of psychedelic medicine - 17:51
• Current evidence and ongoing trials - 27:38
• MDMA and PTSD - 29:26
• Psilocybin and treatment-resistant depression - 32:24
• A word of caution - 34:29
• End-of-life care - 38:47
• Practical aspects of psychedelic-assisted psychotherapy sessions - 45:45
• Safety considerations - 01:04:04
• Future directions - 01:10:33
• Closing comments - 01:19:07

 

Resources:

• Books:
• How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence (Michael Pollan)
• The Doors of Perception (Aldous Huxley)
• The Human Encounter With Death (Stanislav Grof and Joan Halifax)
• Brainwashed podcast series (CBC): https://www.cbc.ca/listen/cbc-podcasts/440-brainwashed
• Zendo Project (psychedelic peer support): https://zendoproject.org
• Nikean Psychedelic Psychotherapy Research Centre: https://www.uhn.ca/MentalHealth/Research/Nikean-Psychedelic-Psychotherapy-Research-Centre
• California Institute of Integral Studies (CIIS): https://www.ciis.edu
• Multidisciplinary Association for Psychedelic Studies (MAPS): https://maps.org
• PsychEd Episode 27 - Serotonin Pharmacology: From SSRIs to Psychedelics with Dr Robin Carhart-Harris)
• PsychEd Episode 34 - Ketamine for Treatment-Resistant Depression with Dr Sandhya Prashad

 

References:

• Carhart-Harris R, Giribaldi B, Watts R, et al. Trial of Psilocybin versus Escitalopram for Depression. N Engl J Med. 2021;384(15):1402-1411. https://doi.org/10.1056/nejmoa2032994
• Carhart-Harris R, Nutt D. Serotonin and brain function: a tale of two receptors. Journal of Psychopharmacology. 2017;31(9):1091-1120. https://doi.org/10.1177/0269881117725915
• Davis AK, Barrett FS, May DG, et al. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2021;78(5):481–489. https://doi.org/10.1001/jamapsychiatry.2020.3285
• Griffiths RR, Johnson MW, Carducci MA, et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J Psychopharmacol. 2016;30(12):1181-1197. dhttps://dx.doi.org/10.1177%2F0269881116675513
• Griffiths RR, Johnson MW, Richards WA, et al. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. J Psychopharmacol. 2018;32(1):49-69. https://doi.org/10.1177/0269881117731279
• Johnson MW, Hendricks PS, Barrett FS, Griffiths RR. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Pharmacol Ther. 2019;197:83-102. https://doi.org/10.1016/j.pharmthera.2018.11.010
• Mitchell JM, Bogenschutz M, Lilienstein A, et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat Med. 2021;27(6):1025-1033. https://doi.org/10.1038/s41591-021-01336-3
• Mithoefer MC, Mithoefer AT, Feduccia AA, et al. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Lancet Psychiatry. 2018;5(6):486-497. https://doi.org/10.1016/s2215-0366(18)30135-4
• Nicholas CR, Henriquez KM, Gassman MC, et al. High dose psilocybin is associated with positive subjective effects in healthy volunteers. J Psychopharmacol. 2018;32(7):770-778. https://doi.org/10.1177/0269881118780713
• Reiff CM, Richman EE, Nemeroff CB, et al. Psychedelics and Psychedelic-Assisted Psychotherapy. Am J Psychiatry. 2020;177(5):391-410. https://doi.org/10.1176/appi.ajp.2019.19010035
• Rosenbaum D, Boyle AB, Rosenblum AM, Ziai S, Chasen MR, Med MP. Psychedelics for psychological and existential distress in palliative and cancer care. Curr Oncol. 2019;26(4):225-226. https://dx.doi.org/10.3747%2Fco.26.5009
• Swift TC, Belser AB, Agin-Liebes G, et al. Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress. Journal of Humanistic Psychology. 2017;57(5):488-519. https://doi.org/10.1177/0022167817715966

 

CPA Note: The views expressed in this podcast do not necessarily reflect those of the Canadian Psychiatric Association.

 

For more PsychEd, follow us on Twitter (@psychedpodcast), Facebook (PsychEd Podcast), and Instagram (@psyched.podcast). You can provide feedback by email at [email protected]. For more information, visit our website at psychedpodcast.org.

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers interpersonal psychotherapy (IPT) with Dr. Paula Ravitz, an Associate Professor of Psychiatry at the University of Toronto and Senior Clinician-Scientist at the Lunenfeld-Tanenbaum Research Institute of Mt Sinai Hospital. Dr. Ravitz held the Morgan Firestone Psychotherapy Chair at the Mount Sinai Hospital from 2011 to 2021 and is a past president of the International Society of Interpersonal Psychotherapy.

The learning objectives for this episode are as follows:

By the end of this episode, you should be able to…

1. Define interpersonal psychotherapy
2. Describe the core principles and phases of IPT
3. Become familiarized with some psychological theories underpinning IPT
4. List some patient selection considerations for IPT
5. Describe the efficacy and evidence base for IPT 
6. Understand how IPT is practically carried  out 
7. Briefly compare and contrast IPT to other common psychotherapies

Guest: Dr. Paula Ravitz ([email protected])

Hosts: Jake Johnston and Sena Gok

Audio editing by: Jake Johnston

Show notes by: Jake Johnston

Interview Content:

• Introduction - 00:00
• Learning objectives - 02:10
• Definition/overview of IPT - 02:53
• Core principles and phases - 07:20
• Psychological theories - 19:30
• Patient selection considerations - 24:42
• Contraindications - 35:57
• Evidence base and history - 38:10
• Practical components of IPT - 43:57
• Maintenance IPT - 59:52
• IPT vs other psychotherapies - 62:56 
• Closing comments - 71:17
• Online IPT course - 74:30

Resources:

• Summary of IPT written in layman's terms: https://www.camh.ca/en/health-info/mental-illness-and-addiction-index/interpersonal-psychotherapy
• The International Society of Interpersonal Psychotherapy (ISIPT) has a helpful overview of IPT and helpful resources for finding more information and IPT training opportunities: https://interpersonalpsychotherapy.org/
• ‘Psychotherapy Essentials to Go’ book series mentioned during episode:  https://www.penguinrandomhouse.ca/series/CNL/psychotherapy-essentials-to-go
• The online IPT curriculum is now available as a University of Toronto, Faculty of Medicine-sponsored open-access online course through Coursera, that is free for learners to audit - https://www.coursera.org/learn/learn-ipt

References:

• Bernecker, S. L., Coyne, A. E., Constantino, M. J., & Ravitz, P. (2017). For whom does interpersonal psychotherapy work? A systematic review. Clinical psychology review, 56, 82–93. https://doi.org/10.1016/j.cpr.2017.07.001
• Chaimowitz, G., Weerasekera, P., & Ravitz, P. (2021). Psychotherapy in Psychiatry. The Canadian Journal of Psychiatry, 66(11), 999–1004. https://doi.org/10.1177/07067437211040958
• Cuijpers, P., Donker, T., Weissman, M. M., Ravitz, P., & Cristea, I. A. (2016). Interpersonal Psychotherapy for Mental Health Problems: A Comprehensive Meta-Analysis. The American journal of psychiatry, 173(7), 680–687. https://doi.org/10.1176/appi.ajp.2015.15091141 
• Dennis, C. L., Grigoriadis, S., Zupancic, J., Kiss, A., & Ravitz, P. (2020). Telephone-based nurse-delivered interpersonal psychotherapy for postpartum depression: nationwide randomised controlled trial. The British journal of psychiatry : the journal of mental science, 216(4), 189–196. https://doi.org/10.1192/bjp.2019.275 
• Elkin, I., Shea, M. T., Watkins, J. T., Imber, S. D., Sotsky, S. M., Collins, J. F., Glass, D. R., Pilkonis, P. A., Leber, W. R., & Docherty, J. P. (1989). National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Archives of general psychiatry, 46(11), 971–983. https://doi.org/10.1001/archpsyc.1989.01810110013002
• Klerman, G. L., Dimascio, A., Weissman, M., Prusoff, B., & Paykel, E. S. (1974). Treatment of depression by drugs and psychotherapy. The American journal of psychiatry, 131(2), 186–191. https://doi.org/10.1176/ajp.131.2.186 
• MacQueen, G. M., Frey, B. N., Ismail, Z., Jaworska, N., Steiner, M., Lieshout, R. J., Kennedy, S. H., Lam, R. W., Milev, R. V., Parikh, S. V., Ravindran, A. V., & CANMAT Depression Work Group (2016). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 61(9), 588–603. https://doi.org/10.1177/0706743716659276
• Parikh, S. V., Quilty, L. C., Ravitz, P., Rosenbluth, M., Pavlova, B., Grigoriadis, S., Velyvis, V., Kennedy, S. H., Lam, R. W., MacQueen, G. M., Milev, R. V., Ravindran, A. V., Uher, R., & CANMAT Depression Work Group (2016). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 61(9), 524–539. https://doi.org/10.1177/0706743716659418
• Ravitz, P., & Watson, P. (2014). Interpersonal Psychotherapy: Healing with a Relational Focus. FOCUS, 12(3), 275-284. https://doi.org/10.1176/appi.focus.12.3.275
• Ravitz, P., Watson, P., Lawson, A., Constantino, M. J., Bernecker, S., Park, J., & Swartz, H. A. (2019). Interpersonal Psychotherapy: A Scoping Review and Historical Perspective (1974-2017). Harvard review of psychiatry, 27(3), 165–180. https://doi.org/10.1097/HRP.0000000000000219
• Swartz, H. (2021). Interpersonal Psychotherapy (IPT) for depressed adults: Indications, theoretical foundation, general concepts, and efficacy. UpToDate. Accessed 2021-10-12.

For more PsychEd, follow us on Twitter (@psychedpodcast), Facebook (PsychEd Podcast), and Instagram (@psyched.podcast). You can provide feedback by email at [email protected]. For more information, visit our website at psychedpodcast.org.

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers Medical Assistance in Dying (MAiD) and mental illness with our guest expert Dr. Sonu Gaind. This episode was originated by Dr. Urvashi Prasad for her Grand Rounds. 

 

The learning objectives for this episode are as follows:

By the end of this episode, you should be able to…

1. Briefly summarize the history of Medical Assistance in Dying in Canada
2. Define the present policy on Medical Assistance in Dying and Mental Health in Canada
3. Evaluate the arguments in support of and against the implementation of Medical Assistance in Dying in Mental Health
4. Discuss the possible impact that Medical Assistance in Dying might have on the profession of psychiatry

 

Guest expert: Dr. Sonu Gaind  is a Professor in the Faculty of Medicine at the University of Toronto (U of T) and Chief of Psychiatry at Humber River Hospital. Dr. Gaind has testified in front of the Federal External Panel on Options for a Legislative Response to Carter v. Canada, the Provincial-Territorial Expert Advisory Group on Physician-Assisted Dying, the Special Joint Commons/Senate Committee on Physician-Assisted Dying, and the Senate Committee on Legal and Constitutional Affairs on issues relevant to mental health and mental illness that need to be considered in the MAiD framework. Dr. Gaind chaired the time-limited Canadian Psychiatric Association Task Force on Assisted Dying, was selected to sit on the Council of Canadian Academies Expert Panel on Mental Disorders and Assisted Dying, and has spoken across the country and internationally on the subject.

 

Grand Rounds Presenter: Dr. Urvashi Prasad (PGY3)

 

Produced by: Dr. Urvashi Prasad (PGY3) and Dr. Alex Raben  (staff psychiatrist)

 

Hosts: David Eapen-John (MS2), Dr. Alex Raben (Staff Psychiatrist)

 

Audio editing by: Dr. Alex Raben (Staff Psychiatrist)

 

Show notes by: Dr. Urvashi Prasad (PGY3)

 

 

Resources:

Assisted Suicide in Canada https://www.thecanadianencyclopedia.ca/en/article/assisted-suicide-in-canada (Website)

Council of Canadian Academies, 2018. The State of Knowledge on Medical Assistance in Dying Where a Mental Disorder Is the Sole Underlying Medical Condition. Ottawa (ON):  The Expert Panel Working Group on MAID Where a Mental Disorder Is the Sole Underlying Medical Condition 

https://cca-reports.ca/wp-content/uploads/2018/12/The-State-of-Knowledge-on-Medical-Assistance-in-Dying-Where-a-Mental-Disorder-is-the-Sole-Underlying-Medical-Condition.pdf

References:

• Government of Ontario, Ministry of Health and Long-Term Care. “Medical Assistance in Dying.” Health Care Professionals - MOH, Government of Ontario, Ministry of Health and Long-Term Care, 13 May 2021, https://www.health.gov.on.ca/en/pro/programs/maid/.
• Tabitha Marshall. “Assisted Suicide in Canada.” The Canadian Encyclopedia, 3 Dec. 2021, https://www.thecanadianencyclopedia.ca/en/article/assisted-suicide-in-canada.
• “Get the Facts: Canada's Medical Assistance in Dying Law.” Dying With Dignity Canada, https://www.dyingwithdignity.ca/get_the_facts_assisted_dying_law_in_canada#mental_illness.
• Jones, Roland M, and Alexander I F Simpson. “ Medical Assistance in Dying: Challenges for Psychiatry.” Frontiers in psychiatry vol. 9 678. 10 Dec. 2018, doi:10.3389/fpsyt.2018.00678
• Thienpont, Lieve et al. “Euthanasia requests, procedures and outcomes for 100 Belgian patients

suffering from psychiatric disorders: a retrospective, descriptive study.” BMJ open vol. 5,7

e007454. 27 Jul. 2015, doi:10.1136/bmjopen-2014-007454

• Gaind, KS. (2020). What does “irremediability” in mental illness mean? Canadian Journal of

Psychiatry. Online first May 22, 2020. pp 1‐3. doi: 10.1177/0706743720928656

• “Maid Volunteer Advocacy Council.” Mental Illness and MAID, https://sencanada.ca/content/sen/committee/432/LCJC/Briefs/MentalIllnessandMAID_e.pdf.
• Canada, Health. “Second Annual Report on Medical Assistance in Dying in Canada 2020.” Canada.ca, / Government of Canada Gouvernement Du Canada, 30 June 2021, https://www.canada.ca/en/health-canada/services/medical-assistance-dying/annual-report-2020.html#highlights. 
• Komrad, Mark S. “Oh, Canada! Your New Law Will Provide, Not Prevent, Suicide for Some Psychiatric Patients.” Psychiatric Times, 1 June 2021, https://www.psychiatrictimes.com/view/canada-law-provide-not-prevent-suicide. 

 

 

CPA Note: The views expressed in this podcast do not necessarily reflect those of the Canadian Psychiatric Association (CPA).

For more PsychEd, follow us on Twitter (@psychedpodcast), Facebook (PsychEd Podcast), and Instagram (@psyched.podcast). You can provide feedback by email at [email protected]. For more information, visit our website at psychedpodcast.org.